Literature DB >> 21596846

SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis.

Hedia Chagraoui1, Mira Kassouf, Sreemoti Banerjee, Nicolas Goardon, Kevin Clark, Ann Atzberger, Andrew C Pearce, Radek C Skoda, David J P Ferguson, Steve P Watson, Paresh Vyas, Catherine Porcher.   

Abstract

Megakaryopoiesis is a complex process that involves major cellular and nuclear changes and relies on controlled coordination of cellular proliferation and differentiation. These mechanisms are orchestrated in part by transcriptional regulators. The key hematopoietic transcription factor stem cell leukemia (SCL)/TAL1 is required in early hematopoietic progenitors for specification of the megakaryocytic lineage. These early functions have, so far, prevented full investigation of its role in megakaryocyte development in loss-of-function studies. Here, we report that SCL critically controls terminal megakaryocyte maturation. In vivo deletion of Scl specifically in the megakaryocytic lineage affects all key attributes of megakaryocyte progenitors (MkPs), namely, proliferation, ploidization, cytoplasmic maturation, and platelet release. Genome-wide expression analysis reveals increased expression of the cell-cycle regulator p21 in Scl-deleted MkPs. Importantly, p21 knockdown-mediated rescue of Scl-mutant MkPs shows full restoration of cell-cycle progression and partial rescue of the nuclear and cytoplasmic maturation defects. Therefore, SCL-mediated transcriptional control of p21 is essential for terminal maturation of MkPs. Our study provides a mechanistic link between a major hematopoietic transcriptional regulator, cell-cycle progression, and megakaryocytic differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596846     DOI: 10.1182/blood-2011-01-328765

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

Review 1.  Normal and malignant megakaryopoiesis.

Authors:  Qiang Wen; Benjamin Goldenson; John D Crispino
Journal:  Expert Rev Mol Med       Date:  2011-10-21       Impact factor: 5.600

Review 2.  Endoreplication and polyploidy: insights into development and disease.

Authors:  Donald T Fox; Robert J Duronio
Journal:  Development       Date:  2013-01-01       Impact factor: 6.868

3.  SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.

Authors:  Miguel G Toscano; Oscar Navarro-Montero; Veronica Ayllon; Veronica Ramos-Mejia; Xiomara Guerrero-Carreno; Clara Bueno; Tamara Romero; Mar Lamolda; Marien Cobo; Francisco Martin; Pablo Menendez; Pedro J Real
Journal:  Mol Ther       Date:  2014-10-08       Impact factor: 11.454

4.  Cyclic AMP signaling inhibits megakaryocytic differentiation by targeting transcription factor 3 (E2A) cyclin-dependent kinase inhibitor 1A (CDKN1A) transcriptional axis.

Authors:  Jeremy D Rubinstein; Kamaleldin E Elagib; Adam N Goldfarb
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

5.  JAK2V617F-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation.

Authors:  H Zhan; Y Ma; C H S Lin; K Kaushansky
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

6.  JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling.

Authors:  Yu Zhang; Chi Hua Sarah Lin; Kenneth Kaushansky; Huichun Zhan
Journal:  Stem Cells       Date:  2018-07-29       Impact factor: 6.277

Review 7.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

8.  CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development.

Authors:  Brenda A Finney; Edina Schweighoffer; Leyre Navarro-Núñez; Cecile Bénézech; Francesca Barone; Craig E Hughes; Stacey A Langan; Kate L Lowe; Alice Y Pollitt; Diego Mourao-Sa; Steve Sheardown; Gerard B Nash; Nicholas Smithers; Caetano Reis e Sousa; Victor L J Tybulewicz; Steve P Watson
Journal:  Blood       Date:  2011-12-20       Impact factor: 22.113

9.  Establishment of an ES cell-derived murine megakaryocytic cell line, MKD1, with features of primary megakaryocyte progenitors.

Authors:  Hedia Chagraoui; Catherine Porcher
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

10.  Lineage tracing of Pf4-Cre marks hematopoietic stem cells and their progeny.

Authors:  Simon D J Calaminus; Amelie V Guitart; Amelie Guitart; Amy Sinclair; Hannah Schachtner; Steve P Watson; Tessa L Holyoake; Kamil R Kranc; Laura M Machesky
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.